Exploring definitions and predictors of response to biologics for severe asthma

- Scelo, Ghislaine, Tran, Trung N., Bergeron, Celine, Bjermer, Leif, Bjerrum, Anne S., Cano-Rosales, Diana Jimena, Canonica, Giorgio Walter, Carter, Victoria, Charriot, Jeremy, Christoff, George C., Cosio, Borja G., Denton, Eve, Le, Tham T., Fernandez-Sanchez, Maria Jose, Fonseca, JA, Gibson, Peter G., Goh, C, Heaney, LG, Heffler, E, Hew, M, Iwanaga, T, Katial, R, Koh, MS, Faregås, Malin, Kuna, P, Larenas-Linnemann, D, Lehtimäki, L, Mahboub, B, Martin, N, Matsumoto, H, Menzies-Gow, AN, Papadopoulos, NG, Patel, P, Perez-De-Llano, L, Dorscheid, Delbert, Peters, M, Pfeffer, PE, Popov, TA, Porsbjerg, CM, Rhee, CK, Sadatsafavi, M, Taillé, C, Torres-Duque, CA, Tsai, M-J, Ulrik, CS, Busby, John, Upham, JW, von Bülow, A, Wang, E, Wechsler, ME, Price, DB, Al-Ahmad, Mona, Al-Lehebi, Riyad, Altraja, Alan, Beastall, Aaron

Impact of initiatinG bioLogics In patients with severe asThma on long-Term OCS or frEquent Rescue steroids (GLITTER): data from the International Severe Asthma Registry

- Chen, Wenjia, Tran, Trung N., Alacqua, Marianna, Al-Ahmad, Mona, Altraja, Alan, Al-Lehebi, Riyad, Bhutani, Mohit, Bjermer, Leif, Bjerrum, Anne-Sofie, Bourdin, Arnaud, von Bülow, Anna, Busby, John, Sadatsafavi, Mohsen, Walter Canonica, Giorgio, Carter, V, Christoff, GC, Cosio, BG, Costello, RW, Fonseca, JA, Gibson, Peter G., Yoo, K-H, Heaney, LG, Heffler, E, Murray, Ruth, Hew, M, Hilberg, O, Hoyte, F, Iwanaga, T, Jackson, DJ, Jones, RC, Koh, MS, Kuna, P, Larenas-Linnemann, D, Lehmann, S, Wong, Nigel Chong Boon, Lehtimäki, L, Lyu, J, Mahboub, B, Maspero, J, Menzies-Gow, AN, Newell, A, Sirena, C, Papadopoulos, NG, Papaioannou, AI, Perez-de-Llano, L, Ali, Nasloon, Perng Steve, D-W, Peters, M, Pfeffer, PE, Porsbjerg, CM, Popov, TA, Rhee, CK, Salvi, S, Taillé, C, Taube, C, Torres-Duque, CA, Ariti, Con, Ulrik, C, Ra, S-W, Wang, E, Wechsler, ME, Price, DB, Bulathsinhala, Lakmini, Gil, Esther Garcia, FitzGerald, J. Mark